Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

23 Feb 2017

Abstract excerpt

BACKGROUND: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating idiopathic disease characterized by unexplained fatigue that fails to resolve with sufficient rest. Diagnosis is based on a list of symptoms and exclusion of other fatigue-related health conditions. Despite a heterogeneous patient population, immune and hypothalamic-pituitary-adrenal (HPA) axis function differences, such as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibromyalgia and Chronic Fatigue Syndrome Research
Share to Genetic Neurodegenerative Diseases
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28231836
DOI: 10.1186/s12920-017-0248-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)PMID 28231836Read ↗

Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue SyndromeSemantic proximity Read ↗

Genome-Epigenome Interactions Associated with Myalgic Encephalomyelitis/Chronic Fatigue SyndromeSemantic proximity Read ↗

Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.Semantic proximity Read ↗

DNA Methylation Modifications Associated with Chronic Fatigue SyndromeSemantic proximity Read ↗

Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patternsSemantic proximity Read ↗

Dynamic Epigenetic Changes during a Relapse and Recovery Cycle in Myalgic Encephalomyelitis/Chronic Fatigue SyndromeSemantic proximity Read ↗

Dynamic Epigenetic Changes during a Relapse and Recovery Cycle in Myalgic Encephalomyelitis/Chronic Fatigue SyndromeSemantic proximity Read ↗

Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender‐specific changes in the microRNA expression profiling in ME/CFSSemantic proximity Read ↗

Comparing DNA Methylation Landscapes in Peripheral Blood from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID PatientsSemantic proximity Read ↗

Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndromeSemantic proximity Read ↗

Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencingSemantic proximity Read ↗

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.